The structural evolution of Bioglass after implantation in the femoral defects
Source abstract
Abstract
Abstract The structural evolution of Bioglass after implantation in the femoral defects was investigated. It indicates that Bioglass directly bonds with new mineralized bone tissue. The rapid releases of Na and Ca ions result in the transformation of Bioglass to the Si-rich layer, and the widths of the Si-rich layers gradually increase to 45 μm at 6 weeks, 100 μm at 12 weeks, and 135 μm at 24 weeks, respectively. The density loss during the transformation of Bioglass to the Si-rich layer is more than 21% after implantation of 6 weeks. The further releases of Ca and Na ions contribute to the disproportionation reaction of Q2 to Q0 and Q4 in the Si-rich layer. Isolated SiO4 tetrahedrons (Q0) are dissolved and absorbed by bone tissue, resulting in the degradation of Bioglass with a decrease in volume. Residual Q4 leads to a more polymerized silica network in the Si-rich layer and a decrease in bioactivity and biodegradation.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. The story of BioglassⓇ10.1007/s10856-006-0432-z ↗
2. Bioactive glasses: from parent 45S5 composition to scaffold-assisted tissue-healing therapies10.3390/jfb9010024 ↗
3. Bioactive materials in orthopaedic surgery: overview and regulatory considerations10.1097/00003086-200202000-00003 ↗
4. Third-generation biomedical materials10.1126/science.1067404 ↗
5. Mechanism of bone-like formation on a bioactive implant in vivo10.1016/S0142-9612(02)00530-6 ↗
6. The Effect of CaF2 on the preparation and in vitro bioactivity of tricalcium silicates
7. Bioactive glasses: where are we and where are we going?10.3390/jfb9010025 ↗
8. Preparation and in vitro bioactivity of zinc incorporating tricalium silicate10.1016/j.msec.2010.11.021 ↗
9. Genetic design of bioactive glass10.1016/j.jeurceramsoc.2008.08.002 ↗
10. The self-setting properties and in vitro bioactivity of tricalcium silicate10.1016/j.biomaterials.2005.04.025 ↗
11. New insights into the atomic structure of 45S5 bioglass by means of solid-state NMR spectroscopy and accurate first-principles simulations10.1021/cm102089c ↗
12. Structural analysis of bioactive glasses10.1016/j.jnoncrysol.2004.07.067 ↗
13. In vivo behaviors of Ca(OH)2 activated nano SiO2 (nCa/nSi= 3) cement in rabbit model10.1016/j.msec.2015.09.032 ↗
14. The reactivity of nano silica with calcium hydroxide10.1002/jbm.b.31891 ↗
15. Influence of magnesia on the structure and properties of bioactive glasses10.1016/j.jnoncrysol.2009.04.074 ↗
16. Influence of atmospheric plasma spraying parameters on porosity formation in coatings manufactured from 45S5 BioglassⓇ powder
17. Effects of Si speciation on the in vitro bioactivity of glasses10.1016/S0142-9612(01)00115-6 ↗
18. Bioactive glass (45S5)-based 3D scaffolds coated with magnesium and zinc-loaded hydroxyapatite nanoparticles for tissue engineering applications10.1016/j.colsurfb.2019.110346 ↗
19. The repair of segmental bone defects with porous bioglass: an experimental study in goat10.1016/j.rvsc.2008.04.008 ↗
20. Novel tricalcium silicate/magnesium phosphate composite bone cement having high compressive strength, in vitro bioactivity and cytocompatibility10.1016/j.actbio.2015.04.012 ↗
21. The story of BioglassⓇ10.1007/s10856-006-0432-z ↗
22. The shape modulation of osteoblast-osteocyte transformation and its correlation with the fibrillar organization in secondary osteons10.1007/s00441-010-0970-z ↗
23. Novel alkali free bioactive fluorapatite glass ceramics10.1016/j.jnoncrysol.2014.05.025 ↗
24. In vitro chemical reactivity of doped bioactive glasses: an original approach by solid-state NMR spectroscopy10.1002/adem.200800400 ↗
25. Influence of the CaO/MgO ratio on the structure of phase-separated glasses: a solid state 29Si and 31P MAS NMR study10.1016/S0022-3093(99)00957-6 ↗
26. Can bioactivity be tested in vitro with SBF solution?10.1016/j.biomaterials.2009.01.008 ↗
27. A comparative study between in vivo bone ingrowth and in vitro apatite formation on Na2O-CaO-SiO2 glasses10.1016/S0142-9612(02)00511-2 ↗
28. Dose- and time-dependent effect of bioactive gel-glass ionic-dissolution products on human fetal osteoblast-specific gene expression10.1002/jbm.b.30249 ↗
29. Cellular mechanisms of calcium phosphate ceramic degradation
30. Innovative silicate-based cements for endodontics: a study of osteoblast-like cell response10.1002/jbm.a.31795 ↗
31. Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass conditioned medium in the absence of osteogenic supplements10.1016/j.biomaterials.2009.03.019 ↗
32. Quantitative composition–bioactivity relationships of phosphosilicate glasses: bearings from the phosphorus content and network polymerization10.1016/j.jnoncrysol.2018.07.060 ↗
33. Silicon: the evolution of its use in biomaterials10.1016/j.actbio.2014.09.025 ↗